erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Cho T et al. [Effects of EM on the intracellular Ca 2+ response in A549 cells]. 2000 Jpn J Antibiot pmid:10756443
Nakamura A et al. [Selective suppression of aminoglycoside 3'-phosphorylating enzyme activities by macrolides--a study by using macrolide-resistant bacteria]. 2000 Jpn J Antibiot pmid:10756446
Homa K et al. [Erythromycin sensitivity of Shigella flexneri and S. sonnei]. 2000 Jpn J Antibiot pmid:10756447
Sakamoto M et al. [Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period]. 2000 Jpn J Antibiot pmid:10756453
Miyazawa T and Iino Y [Effect of macrolides on ligand expression by T lymphocytes obtained from human peripheral blood]. 2000 Jpn J Antibiot pmid:10756457
Enomoto F et al. [Involvement of adhesion molecules in experimental otitis media in rats--an in vitro evaluation]. 2000 Jpn J Antibiot pmid:10756459
Obori M et al. [Effects of 14-member cyclic macrolide compounds on rat leukocyte chemotaxis]. 2000 Jpn J Antibiot pmid:10756460
Takahashi T et al. [Efficacy of erythromycin (EM) on a rabbit model of Pseudomonas aeruginosa-induced chronic bronchiolitis--its action on apoptosis]. 2000 Jpn J Antibiot pmid:10756461
Dezaki S et al. [Effects of macrolides on several transcription factors]. 2000 Jpn J Antibiot pmid:10756462
Komiyane M and Tamaoki K [Clinical effects of macrolides on psoriasis vulgaris]. 2000 Jpn J Antibiot pmid:10756468
Cojocaru I et al. [Dermatologic preparations with erythromycin--the correlation of the pharmaceutical form-therapeutic effect]. 1997 Jul-Dec Rev Med Chir Soc Med Nat Iasi pmid:10756791
Fowler SM et al. Amino acid 305 determines catalytic center accessibility in CYP3A4. 2000 Biochemistry pmid:10757990
Curran JB et al. Infection of abnormal heart valves and total joint prosthesis following dental procedures. 1976 Jul-Aug Northwest Dent pmid:1075923
Van Herwaarden MA et al. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. 2000 Aliment. Pharmacol. Ther. pmid:10759625
Douthwaite S et al. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. 2000 Mol. Microbiol. pmid:10760175
Miller P et al. Neural and muscular receptors for motilin in the rabbit colon. 2000 Peptides pmid:10764957
Evans AJ and Krentz AJ Should cisapride be avoided in patients with diabetic gastroparesis? 1999 Sep-Dec J. Diabetes Complicat. pmid:10765008
Osterholm MT Erythromycin remains gold standard for treatment of pertussis in infants. 2000 Clin. Infect. Dis. pmid:10766495
Quirós LM et al. Glycosylation of macrolide antibiotics. Purification and kinetic studies of a macrolide glycosyltransferase from Streptomyces antibioticus. 2000 J. Biol. Chem. pmid:10766792
Suwa M et al. Identification of two polyketide synthase gene clusters on the linear plasmid pSLA2-L in Streptomyces rochei. 2000 Gene pmid:10767533
Nieto JE et al. In vitro effects of erythromycin, lidocaine, and metoclopramide on smooth muscle from the pyloric antrum, proximal portion of the duodenum, and middle portion of the jejunum of horses. 2000 Am. J. Vet. Res. pmid:10772106
Roussel AJ et al. Prokinetic effects of erythromycin on the ileum, cecum, and pelvic flexure of horses during the postoperative period. 2000 Am. J. Vet. Res. pmid:10772107
Ghidini A et al. Successful outcome after antibiotic treatment of postamniocentesis membrane rupture and chorioamnionitis in multiple pregnancy. 1999 Am J Perinatol pmid:10772199
Najib MM et al. Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. 2000 Pharmacotherapy pmid:10772376
Pai MP et al. Macrolide drug interactions: an update. 2000 Ann Pharmacother pmid:10772438
Gunics G et al. Interaction between antibiotics and non-conventional antibiotics on bacteria. 2000 Int. J. Antimicrob. Agents pmid:10773495
Matsuoka M [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]. 2000 Yakugaku Zasshi pmid:10774259
Donders GG Treatment of sexually transmitted bacterial diseases in pregnant women. 2000 Drugs pmid:10776830
Collins JM Cytochrome P-450 and other determinants of pharmacokinetics, toxicity, and efficacy in humans. 2000 Clin. Cancer Res. pmid:10778942
Hirth J et al. The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. 2000 Clin. Cancer Res. pmid:10778948
Sartakova M et al. Development of an extrachromosomal cloning vector system for use in Borrelia burgdorferi. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10781091
Clark RF et al. Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivatives. 2000 Bioorg. Med. Chem. Lett. pmid:10782693
Fanos V et al. Flurithromycin-induced acute interstitial nephritis. 2000 Pediatr. Infect. Dis. J. pmid:10783037
Schwarz UI et al. P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. 2000 Int J Clin Pharmacol Ther pmid:10783825
Graham AE et al. Efficient large-scale radical deoxygenation in alcoholic solvents using sodium hypophosphite and a phase-transfer agent: application to erythromycins. 2000 J. Org. Chem. pmid:10789478
Hoey J Hypertrophic pyloric stenosis caused by erythromycin. 2000 CMAJ pmid:10789643
Khan SA et al. Transfer of erythromycin resistance from poultry to human clinical strains of Staphylococcus aureus. 2000 J. Clin. Microbiol. pmid:10790109
Emerson BB et al. Hemophilus influenzae type B susceptibility to 17 antibiotics. 1975 J. Pediatr. pmid:1079251
Gaisser S et al. A defined system for hybrid macrolide biosynthesis in Saccharopolyspora erythraea. 2000 Mol. Microbiol. pmid:10792725
Sato F et al. EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs. 2000 Eur. J. Pharmacol. pmid:10794824
Petrakis IE et al. Erythromycin enhances solid-phase gastric emptying in induced-hyperglycemia in patients with truncal vagotomy and pyloroplasty. 2000 Dig. Dis. Sci. pmid:10795758
Ng E and Shah V Erythromycin for feeding intolerance in preterm infants. 2000 Cochrane Database Syst Rev pmid:10796273
Arzese AR et al. Detection of tetQ and ermF antibiotic resistance genes in Prevotella and Porphyromonas isolates from clinical specimens and resident microbiota of humans. 2000 J. Antimicrob. Chemother. pmid:10797077
Alós JI et al. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting. 2000 J. Antimicrob. Chemother. pmid:10797081
Rao GG Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? 2000 J. Antimicrob. Chemother. pmid:10797103
Davis SD et al. Partial antibiotic therapy in Haemophilus infuenzae meningitis. Its effect on cerebrospinal fluid abnormalities. 1975 Am. J. Dis. Child. pmid:1080009
Sarna SK et al. Enteric locus of action of prokinetics: ABT-229, motilin, and erythromycin. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10801267
Mardones G and Venegas A Chromogenic plate assay distinguishing bacteriolytic from bacteriostatic activity of an antibiotic agent. 2000 J. Microbiol. Methods pmid:10802135
Lal R et al. Regulation and manipulation of the gene clusters encoding type-I PKSs. 2000 Trends Biotechnol. pmid:10802562
Lecomte T et al. [Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin]. 2000 Gastroenterol. Clin. Biol. pmid:10804347